Index S&P 500
P/E 276.42
EPS (ttm) 0.04
Insider Own 2.01%
Shs Outstand 1.20B
Perf Week 1.30%
Market Cap 13.95B
Forward P/E 4.20
EPS next Y 2.79
Insider Trans -1.43%
Shs Float 1.17B
Perf Month -0.26%
Income 54.70M
PEG -
EPS next Q 0.67
Inst Own 80.61%
Short Float 3.53%
Perf Quarter -1.43%
Sales 15.38B
P/S 0.91
EPS this Y -5.68%
Inst Trans 2.12%
Short Ratio 4.59
Perf Half Y 26.43%
Book/sh 17.05
P/B 0.69
EPS next Y 0.72%
ROA 0.11%
Short Interest 41.14M
Perf Year 26.29%
Cash/sh 0.91
P/C 12.92
EPS next 5Y -2.25%
ROE 0.26%
52W Range 8.74 - 13.62
Perf YTD 8.22%
Dividend Est. 0.51 (4.38%)
P/FCF 5.76
EPS past 5Y -41.87%
ROI 0.15%
52W High -13.93%
Beta 1.00
Dividend TTM 0.48 (4.10%)
Quick Ratio 1.13
Sales past 5Y 7.93%
Gross Margin 42.68%
52W Low 34.10%
ATR (14) 0.25
Dividend Ex-Date Mar 08, 2024
Current Ratio 1.57
EPS Y/Y TTM -97.35%
Oper. Margin 13.50%
RSI (14) 52.78
Volatility 2.05% 2.04%
Employees 38000
Debt/Eq 0.90
Sales Y/Y TTM -4.90%
Profit Margin 0.36%
Recom 3.10
Target Price 12.50
Option/Short Yes / Yes
LT Debt/Eq 0.80
EPS Q/Q -177.06%
Payout 1059.60%
Rel Volume 0.68
Prev Close 11.82
Sales Surprise -1.27%
EPS Surprise -4.05%
Sales Q/Q -0.95%
Earnings May 09 BMO
Avg Volume 8.97M
Price 11.72
SMA20 2.04%
SMA50 -1.13%
SMA200 8.34%
Trades
Volume 6,075,014
Change -0.85%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-23-23 Downgrade
BofA Securities
Neutral → Underperform
$13 → $9
Jun-23-23 Downgrade
Barclays
Equal Weight → Underweight
$11
Apr-24-23 Downgrade
Barclays
Overweight → Equal Weight
$11
Feb-17-23 Downgrade
BMO Capital Markets
Outperform → Market Perform
$16 → $14
Jan-27-23 Upgrade
Jefferies
Hold → Buy
$13 → $15
Nov-10-22 Upgrade
UBS
Sell → Neutral
$9 → $12
Nov-08-22 Upgrade
Piper Sandler
Underweight → Neutral
$10
Oct-21-22 Resumed
Jefferies
Hold
$11
Jun-14-22 Initiated
UBS
Sell
$9
May-10-22 Downgrade
Piper Sandler
Neutral → Underweight
$10
Mar-01-22 Downgrade
Raymond James
Outperform → Mkt Perform
Mar-01-22 Downgrade
BofA Securities
Buy → Neutral
$21 → $13
Jun-15-21 Initiated
Citigroup
Neutral
$16
Apr-07-21 Resumed
RBC Capital Mkts
Outperform
$24
Mar-08-21 Downgrade
Goldman
Buy → Neutral
$20 → $15
Mar-02-21 Downgrade
JP Morgan
Overweight → Neutral
$21 → $18
Feb-26-21 Downgrade
Wolfe Research
Outperform → Peer Perform
$17
Jan-05-21 Initiated
Argus
Hold
Dec-14-20 Initiated
Bernstein
Mkt Perform
$21
Show Previous Ratings
May-06-24 09:50AM
09:16AM
May-02-24 05:00PM
10:01AM
May-01-24 06:30PM
11:07AM
Loading…
Apr-26-24 11:07AM
Apr-21-24 10:39AM
Apr-18-24 09:54AM
Apr-16-24 04:30PM
Apr-15-24 08:00AM
06:59AM
Apr-04-24 06:52AM
06:22AM
Apr-01-24 02:01PM
11:52AM
07:14AM
Loading…
07:14AM
06:59AM
Mar-29-24 11:30AM
Mar-27-24 06:59AM
Mar-18-24 02:00AM
Mar-15-24 12:00PM
Mar-14-24 09:53AM
Mar-11-24 09:45AM
07:24AM
07:06AM
Mar-08-24 05:04AM
Mar-07-24 08:49AM
Mar-05-24 11:52PM
10:38AM
02:56AM
11:24AM
Loading…
Mar-04-24 11:24AM
Feb-28-24 10:43PM
(Thomson Reuters StreetEvents) -7.11%
07:01PM
09:50AM
09:30AM
08:19AM
07:52AM
07:47AM
07:15AM
06:41AM
(Associated Press Finance)
06:34AM
06:30AM
01:00AM
01:00AM
Feb-23-24 11:54AM
09:15AM
Feb-12-24 07:04AM
Feb-05-24 06:59AM
Jan-25-24 04:44AM
Jan-22-24 11:02AM
Jan-16-24 08:17AM
(Investor's Business Daily)
Dec-28-23 07:13PM
Dec-27-23 04:33PM
Dec-21-23 04:05PM
Dec-15-23 05:13PM
04:55PM
04:45PM
04:05PM
Dec-11-23 04:37PM
Dec-07-23 11:31AM
Nov-30-23 07:30AM
Nov-24-23 08:16PM
Nov-22-23 06:38AM
Nov-21-23 06:00PM
05:09AM
Nov-20-23 06:30AM
Nov-17-23 03:00PM
11:32AM
Nov-14-23 08:00AM
Nov-13-23 08:00AM
Nov-10-23 09:30AM
Nov-09-23 03:49AM
12:18AM
Nov-08-23 03:36PM
12:17PM
10:34AM
Nov-07-23 05:25PM
04:27PM
(Associated Press Finance)
04:02PM
Nov-06-23 10:47AM
Nov-05-23 01:27AM
Oct-31-23 11:17AM
10:01AM
05:05AM
Oct-30-23 04:35PM
04:30PM
12:10PM
09:00AM
Oct-29-23 05:35PM
Oct-27-23 08:45AM
Oct-25-23 04:00PM
Oct-24-23 02:44PM
11:02AM
Oct-23-23 12:52PM
09:00AM
Oct-20-23 05:00PM
Oct-18-23 08:00AM
Oct-13-23 09:15AM
Oct-10-23 09:29AM
Oct-08-23 09:45AM
Viatris, Inc. is a global healthcare company, which engages in the provision of access to medicines and sustainable operations. It also offers support services such as diagnostic clinics, educational seminars, and digital tools. The firm operates through the following segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment consists of operations primarily in North America and Europe. The Greater China segment includes operations in mainland China, Taiwan and Hong Kong. The JANZ segment consists of operations in Japan, Australia and New Zealand. The Emerging Markets segment encompasses operations with developing markets and emerging economies including countries in Asia, the Middle East, South and Central America, Africa and Eastern Europe. The company was founded on February 14, 2019 and is headquartered in Canonsburg, PA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Mauro Anthony See Remarks Mar 13 '24 Sale 12.09 250,000 3,023,700 243,044 Mar 15 06:00 PM Campbell Paul See Remarks Mar 05 '24 Sale 12.33 24,353 300,272 153,826 Mar 05 08:36 PM Lyons Dillon JoEllen Director Mar 05 '24 Sale 12.36 20,000 247,200 58,714 Mar 05 08:19 PM Cuneo Andrew See Remarks Mar 04 '24 Option Exercise 0.00 6,838 0 62,542 Mar 05 07:47 PM Malik Rajiv President Mar 04 '24 Option Exercise 0.00 89,514 0 1,027,249 Mar 05 08:09 PM Campbell Paul See Remarks Mar 04 '24 Option Exercise 0.00 19,427 0 185,132 Mar 05 08:36 PM Mauro Anthony See Remarks Mar 04 '24 Option Exercise 0.00 39,784 0 507,164 Mar 05 08:35 PM Ni Xiangyang (Sean) President, Greater China Mar 04 '24 Option Exercise 0.00 8,222 0 112,336 Mar 05 08:09 PM Roman Brian Global General Counsel Mar 04 '24 Option Exercise 0.00 18,650 0 163,817 Mar 05 08:29 PM Ni Xiangyang (Sean) President, Greater China Mar 04 '24 Sale 12.51 21,532 269,314 90,804 Mar 05 08:09 PM Mauro Anthony See Remarks Mar 03 '24 Option Exercise 0.00 37,835 0 485,243 Mar 05 08:35 PM Campbell Paul See Remarks Mar 03 '24 Option Exercise 0.00 18,560 0 174,518 Mar 05 08:36 PM Smith Scott Andrew Chief Executive Officer Mar 03 '24 Option Exercise 0.00 140,727 0 135,829 Mar 05 08:01 PM Malik Rajiv President Mar 03 '24 Option Exercise 0.00 85,788 0 978,180 Mar 05 08:09 PM Lyons Dillon JoEllen Director Mar 03 '24 Option Exercise 0.00 18,855 0 78,714 Mar 05 08:19 PM Cuneo Andrew See Remarks Mar 03 '24 Option Exercise 0.00 13,199 0 61,485 Mar 05 07:47 PM CORNWELL W DON Director Mar 03 '24 Option Exercise 0.00 18,855 0 61,365 Mar 05 08:29 PM Roman Brian Global General Counsel Mar 03 '24 Option Exercise 0.00 17,598 0 153,541 Mar 05 08:29 PM FINNEY ELISHA W Director Mar 03 '24 Option Exercise 0.00 18,855 0 18,855 Mar 05 08:25 PM Groothuis Leo Frans Director Mar 03 '24 Option Exercise 0.00 22,484 0 22,154 Mar 05 08:24 PM KILTS JAMES M Director Mar 03 '24 Option Exercise 0.00 18,855 0 117,445 Mar 05 08:22 PM KORMAN HARRY Director Mar 03 '24 Option Exercise 0.00 18,855 0 89,806 Mar 05 08:23 PM PARRISH MARK W Director Mar 03 '24 Option Exercise 0.00 18,855 0 121,418 Mar 05 08:17 PM MARK RICHARD A Director Mar 03 '24 Option Exercise 0.00 18,855 0 72,333 Mar 05 08:14 PM HIGGINS MELINA E Director Mar 03 '24 Option Exercise 0.00 18,855 0 102,236 Mar 05 08:13 PM Ni Xiangyang (Sean) President, Greater China Mar 03 '24 Option Exercise 0.00 14,298 0 104,114 Mar 05 08:09 PM Ni Xiangyang (Sean) President, Greater China Mar 02 '24 Option Exercise 0.00 25,158 0 89,816 Mar 05 08:09 PM Roman Brian Global General Counsel Mar 02 '24 Option Exercise 0.00 84,277 0 158,905 Mar 05 08:29 PM Cuneo Andrew See Remarks Mar 02 '24 Option Exercise 0.00 25,692 0 52,167 Mar 05 07:47 PM Malik Rajiv President Mar 02 '24 Option Exercise 0.00 433,416 0 1,008,849 Mar 05 08:09 PM Campbell Paul See Remarks Mar 02 '24 Option Exercise 0.00 90,297 0 180,524 Mar 05 08:36 PM Mauro Anthony See Remarks Mar 02 '24 Option Exercise 0.00 192,630 0 499,154 Mar 05 08:35 PM Cuneo Andrew See Remarks Feb 23 '24 Sale 13.50 4,000 54,000 34,795 Feb 23 06:00 PM Cuneo Andrew See Remarks Feb 15 '24 Sale 12.50 4,000 50,000 38,795 Feb 16 06:00 PM Cuneo Andrew See Remarks Jan 04 '24 Sale 11.50 4,000 46,000 42,795 Jan 05 06:00 PM Cuneo Andrew See Remarks Dec 14 '23 Sale 10.50 4,000 42,000 46,795 Dec 15 06:00 PM Ni Xiangyang (Sean) President, Greater China Nov 24 '23 Sale 9.37 14,937 139,942 64,658 Nov 24 06:00 PM Ni Xiangyang (Sean) President, Greater China Nov 23 '23 Option Exercise 0.00 33,179 0 79,595 Nov 24 06:00 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite